The CD9 Molecule on Stromal Cells

References

• Maecker H. T., Todd S. C., Levy S. The tetraspanin superfamily. molecular facilitators. FASEB J 1997; 11: 428–442
   PubMed Web of Science ®Google Scholar
• Lee K. W., Shalaby K. A., Medhat A. M., Shi H., Yang Q., Karim A. M., LoVerde P. T. Schistosoma man-soni: characterization of the gene encoding Sm23, an integral membrane protein. Exp Parasitol 1995; 80: 155–158
   PubMed Web of Science ®Google Scholar
• Wilson R., Ainscough R., Anderson K., Baynes C., Berks M., Bonfield J., Burton J., Connell M., Copsey T., Cooper J. 2.2 Mb of contiguous nucleotide sequence from chromosome HI of C. elegans. Nature 1994; 368: 32–38
   PubMed Web of Science ®Google Scholar
• Kopczynski C. C., Davis G. W., Goodman C. S. A neural tetraspanin, encoded by late bloomer, that facilitates synapse formation. Science 1996; 271: 1867–70
   PubMed Web of Science ®Google Scholar
• Kersey J., Le Bien T, Abranson C. S., Newman R., Sutherland R., Greaves M. p24 a human leukemia associated and lymphohematopoietic progenitor cell surface structure identified with monoclonal antibody. J Exp Med 1981; 153: 726–731
   PubMed Web of Science ®Google Scholar
• Jones N. H., Borowitz M. J., Metzgar R. S. Characterization and distribution of a 24,000-molecular weight antigen defined by a monoclonal antibody (DU-ALL-1) elicited to common acute lymphoblastic leukemia (cALL) cells. Leuk Res 1982; 6: 449–464
   PubMed Web of Science ®Google Scholar
• Lanza F., Wolf D., Fox C. F., Kieffer N., Seyer J. M., Fried V. A., Coughlin S. R., Phillips D. R., Jennings L. K. cDNA cloning and expression of platelet p24/CD9. Evidence for a new family of multiple membrane-spanning proteins. J Biol Chem 1991; 266: 10638–10645
   PubMed Web of Science ®Google Scholar
• Boucheix C., Benoit P., Frachet P., Billard M., Worthington R. E., Gagnon J., Uzan G. Molecular cloning of the CD9 antigen. A new family of cell surface proteins. J Bio Chem 1991; 266: 117–122
   PubMed Web of Science ®Google Scholar
• Miyake M., Koyama M., Seno M., Ikeyama S. Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31–15, which inhibits cell motility. J Exp Med 1991; 174: 1347–1354
   PubMed Web of Science ®Google Scholar
• Seehafer J. G., Shaw A. R. Evidence that the signal-initiating membrane protein CD9 is associated with small GTP-binding proteins. Biochem Biophys Res Commun 1991; 179: 401–406
   PubMed Web of Science ®Google Scholar
• Tole S., Patterson P H. Distribution of CD9 in the developing and mature rat nervous system. Dev Dyn 1993; 197: 94–106
   PubMed Web of Science ®Google Scholar
• Oritani K., Wu X., Medina K., Hudson J., Miyake K., Gimble J. M., Burstein S. A., Kincade P. W. Antibody ligation of CD9 modifies production of myeloid cells in long-term cultures. Blood 1996; 87: 2252–2261
   PubMed Web of Science ®Google Scholar
• Borghesi L. A., Smithson G., Kincade P. W. Stromal cell modulation of negative regulatory signals that influence apoptosis and proliferation of B lineage lymphocytes. J Immunol 1997; 159: 4171–4179
   PubMed Web of Science ®Google Scholar
• Tanio Y., Yamazaki H., Kunisada T., Miyake K., Hayashi S. I. CD9 molecule expressed on stromal cells is involved in osteoclastogenesis. Exp Hematol 1999; 27: 853–859
   PubMed Web of Science ®Google Scholar
• Kincade P. W., Oritani K., Zheng Z., Borghesi L., Smithson G., Yamashita Y. Cell interaction molecules utilized in bone marrow. Cell Adhes Commun 1998; 6: 211–215
   PubMed Web of Science ®Google Scholar
• Aoyama K., Oritani K., Yokota T., Ishikawa J., Nishiura T., Miyake K., Kanakura Y., Tomiyama Y., Kincade P. W., Matsuzawa Y. Stromal cell CD9 regulates differentiation of hematopoietic stem/progenitor cells. Blood 1999; 93: 2586–2594
   PubMed Web of Science ®Google Scholar
• Mundy G. R., Roodman G. D. Osteoclast ontogeny and function. Bone Miner. Res, W. A. Peck. Elsevier Science Publishers B V., OxfordUK 1987; 209–279
   Google Scholar
• Suda T., Udagawa N., Takahashi N. Cells of bone: Osteoclast generation. Principles of Bone Biology, J. P. Bilezikian, L. G. Raisz, G. A. Roden. Academic Press Inc., New York, NY 1996; 87–102
   Google Scholar
• Hayashi S. I., Yamane T., Miyamoto A., Hemmi H., Tagaya H., Tanio Y, Kanda H., Yamazaki H., Kunisada T. Commitment and differentiation of stem cells to the osteoclast lineage. Biochem Cell Biol 1998; 76: 911–922
   PubMed Web of Science ®Google Scholar
• Udagawa N., Takahashi N., Akatsu T., Sasaki T, Yamaguchi A., Kodama H., Martin T. J., Suda T. The bone marrow-derived stromal cell line MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology 1989; 125: 1805–1813
   PubMed Web of Science ®Google Scholar
• Athanasou N. A., Quinn J., Heryet A., McGee J. O. Localization of platelet antigens and fibrinogen on osteoclasts. J Cell Sci 1988; 89: 115–122
   PubMed Web of Science ®Google Scholar
• Yoshida H., Hayashi S. I., Kunisada T., Ogawa M., Nishikawa S., Okamura H., Sudo T, Shultz L. D., Nishikawa S. I. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 1990; 345: 442–444
   PubMed Web of Science ®Google Scholar
• Yasuda H., Shima N., Nakagawa N., Yamaguchi K., Kinosaki M., Mochizuki S. I., Tomoyasu A., Yano K., Goto M., Murakami A., Tsuda E., Morinaga T., Higashio K., Udagawa N., Takahashi N., Suda T. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. USA 1998; 95: 3597–3602
   PubMed Web of Science ®Google Scholar
• Lacey D. L., Timms E., Tan H. L., Kelley M. J., Dunstan C. R., Burgess T., Elliott R., Colombero A., Elliott G., Scully S., Hsu H, Sullivan J., Hawkins N., Davy E., Capparelli C., Eli A., Qian Y. X., Kaufman S., Sarosi I., Shalhoub V., Senaldi G., Guo J., Delaney J., Boyle W. J. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998; 93: 165–176
   PubMed Web of Science ®Google Scholar
• Kong Y. Y., Yoshida H., Sarosi I., Tan H. L., Timms E., Capparelli C., Morony S., Oliveira-dos-Santos A. J., Van G., Itie A., Khoo W., Wakeham A., Dunstan C. R., Lacey D. L., Mak T. W., Boyle W. J., Penninger J. M. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999; 397: 315–323
   PubMed Web of Science ®Google Scholar
• Simonet W. S., Lacey D. L., Dunstan C. R., Kelley M., Chang M. S., Lufhy R., Nguyen H. Q., Wooden S., Bennett L., Boone T., Shimamoto G., DeRose M., Elliott R., Colombero A., Tan H. L., Trail G., Sullivan J., Davy E., Bucay N., Renshaw-Gegg L., Hughes T. M., Hill D., Patti-Son W., Campbell P., Boyle W. J. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 1997; 89: 309–319
   PubMed Web of Science ®Google Scholar
• Yasuda H., Shima N., Nakagawa N., Mochizuki S., Yano K., Fujise N., Sato Y., Goto M., Yamaguchi K., Kuriyama M., Morinaga T., Higashio K. Identity of osteo-clastgenesis inhibitory factor (OCIF) and osteoprogerin (OPG): A mechanism by which OPG/OCIF inhibits osteo-clastogenesis in vitro. Endocrinology 1998; 13: 1329–1337
   Google Scholar
• Bucay N., Sarosi I., Dunstan C. R., Morony S., Tarpley J., Capparelli C., Scully S., Tan H. L., Xu W., Lacey D. L., Boyle W. J., Simonet W. S. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 1998; 12: 1260–1268
   PubMed Web of Science ®Google Scholar
• Miyaura C., Onoe Y., Inada M, Maki K., Ikuta K., Ito M., Suda T. Increased B-lymphopoiesis by inter-leukin 7 induces bone loss in mice with intact ovarian function: similarity to estrogen deficiency. Proc Natl Acad Sci USA 1997; 94: 9360–9365
   PubMed Web of Science ®Google Scholar
• Rubinstein E., Le Naour F., Lagaudriere-Gesbert C., Biflard M., Conjeaud H., Boucheix C. CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins. Eur J Immunol 1996; 26: 2657–2665
   PubMed Web of Science ®Google Scholar
• Berditchevski F., Zutter M M., Hemler M. E. Characterization of novel complexes on the cell surface between integrins and proteins with 4 domains (TM4 proteins). Mol Biol Cell 1996; 7: 193–207
   PubMed Web of Science ®Google Scholar
• Griffith L., Slupsky J., Seehafer J., Boshkov L., Shaw A. R. Platelet activation by immobilized monoclonal antibody: evidence for a CD9 proximal signal. Blood 1991; 78: 1753–1759
   PubMed Web of Science ®Google Scholar
• Naglich J. G., Metherall J. E., Russell D. W., Eidels L. Expression cloning of a diphtheria toxin receptor: identity with a heparin-binding EGF-like growth factor precursor. Cell 1992; 69: 1051–1061
   PubMed Web of Science ®Google Scholar
• Mitamura T., Iwamoto R., Umata T., Yomo T., Urabe I., Tsuneoka M., Mekada E. The 27-kD diphtheria toxin receptor-associated protein (DRAP27) from Vero cells is the monkey homologue of human CD9 antigen: expression of DRAP27 elevates the number of diphtheria toxin receptors on toxin-sensitive cells. J Cell Biol 1992; 118: 1389–1399
   PubMed Web of Science ®Google Scholar
• Tai X. G., Yashiro Y., Abe R., Toyooka K., Wood C. R., Morris J., Long A., Ono S., Kobayashi M., Hamaoka T., Neben S., Fujiwara H. A role for CD9 molecules in T cell activation. J Exp Med 1996; 184: 753–758
   PubMed Web of Science ®Google Scholar
• Tachibana I., Hemler M. E. Role of transmembrane 4 superfamily (TM4SF) proteins CD9 and CD81 in muscle cell fusion and myotube maintenance. J Cell Biol. 1999; 146: 893–904
   PubMed Web of Science ®Google Scholar
• Maecker H. T., Levy S. Normal lymphocyte development but delayed humoral immune response in CD81-null mice. J Exp Med 1997; 185: 1505–1510
   PubMed Web of Science ®Google Scholar
• Tsitsikov E. N., Gutierrez-Ramos J. C., Geha R. S. impaired CD 19 expression and signaling, enhanced antibody response to type II T independent antigen and reduction of B-l cells in CD81-deficient mice. Proc Natl Acad Sci USA 1997; 94: 10844–10849
   PubMed Web of Science ®Google Scholar
• Ikeyama S., Koyama M., Yamaoko M., Sasada R., Miyake M. Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J Exp Med 1993; 177: 1231–1237
   PubMed Web of Science ®Google Scholar